CD8A and central nervous system cancer: FACS analysis revealed an inversion of the CD4/CD8 ratio in untreated glioma-bearing mice, in which case data were 3.14 ± 0.4 (CD4+)/1.80 ± 0.07 (CD8+), giving a ratio of 1.74.